Catalyst Wire Dossier Catalyst Wire Dossier

CB-03-01

· Intrepid Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CB-03-01, covering 2017-03-13 to 2017-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia [Phase 2]

See pricing